Lv1
73 积分 2021-08-20 加入
Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study
7天前
已完结
Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study
25天前
已完结
Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study
1个月前
已完结
Low-dose chemotherapy remodels hepatic immune landscape and potentiates anti-tumor response to immune checkpoint blockade in cholangiocarcinoma
1个月前
已完结
Shaping the Future of HER2-Directed Therapy in Biliary Tract Cancer
1个月前
已完结
Neuroendocrine Carcinoma of the Gallbladder
3个月前
已完结
Integrative proteogenomic analysis provides molecular insights and clinical significance in gallbladder cancer
3个月前
已完结
Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial
4个月前
已完结
Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials
4个月前
已完结
Abstract LB365: Results from a phase 1 study of botensilimab and balstilimab in treatment refractory hepatocellular carcinoma
5个月前
已关闭
皖公网安备34019202002308
